To view enhanced content for this article go to http://www.medengine.com/Redeem/72C4F0601857FBF0.
The contribution of the author Francesco Oddone to this work was supported by the Italian Ministry of Health and by Fondazione Roma.
An erratum to this article can be found at http://dx.doi.org/10.1007/s12325-016-0342-5.
The ultimate goal of glaucoma management is the preservation of patients’ visual function and quality of life (QoL). The disease itself as well as the medical or surgical treatment can have an enormous impact on a patient’s QoL. Even the mere diagnosis of a chronic, irreversible, potentially blinding disorder can adversely affect the patient’s sense of well-being and QoL by eliciting significant anxiety. Patients with primary open-angle glaucoma rarely present with visual symptoms, at least early in the course of the disease. A better understanding of patient-reported QoL can improve patient–physician interaction and enhance treatment adherence by customizing treatment options based on individual patient profile, thus optimizing long-term prognosis. These aspects are summarized and critically appraised in this article.
Division of Mental Health and Prevention of Substance Abuse WHO. Measuring quality of life. 1997. http://www.who.int/mental_health/media/68.pdf. Accessed 1 Jan 2016.
Courtney-Long E, Carroll D, Zhang Q, et al. Prevalence of disability and disability type among adults—United States. MMWR Morb Mortal Wkly Rep. 2013;2015:777–83.
American Academy of Ophtalmology. Eye disease statistics. 2015: American Academy of Ophthalmology Guidelines.
Broman AT, Munoz B, Rodriguez J, et al. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci. 2002;43:3393–8. PubMed
Bullinger M. Ensuring international equivalence of quality of life measures: problems and approaches to solution. In: Orley J, Kuyken W, editors. Quality of life assessment: international perspectives. Heidelberg: Springer; 1994. p. 33–40. CrossRef
Vandenbroeck S, De Geest S, Zeyen T, Stalmans I, Dobbels F. Patient-reported outcomes (PRO’s) in glaucoma: a systematic review. Eye (Lond). 2011;25:555–77. CrossRef
Turano KA, Geruschat DR, Stahl JW, Massof RW. Perceived visual ability for independent mobility in persons with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1999;40:865–77. PubMed
Turano KA, Massof RW, Quigley HA. A self-assessment instrument designed for measuring independent mobility in RP patients: generalizability to glaucoma patients. Invest Ophthalmol Vis Sci. 2002;43:2874–81. PubMed
Mangione CM, Berry S, Spritzer K, et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol. 1998;116:227–33. PubMed
Day DG, Sharpe ED, Atkinson MJ, Stewart JA, Stewart WC. The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye (Lond). 2006;20:583–90. CrossRef
European Glaucoma Society. Terminology and guidelines for glaucoma. IV ed. Savona: Editrice DOGMA; 2014.
National Institute for Health and Care Excellence. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension [CG85]. London: National Collaborating Centre for Acute Care; 2009.
Peters D, Heijl A, Brenner L, Bengtsson B. Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up. Acta Ophthalmol. 2015;93:745–52.
Iester M, Zingirian M. Quality of life in patients with early, moderate and advanced glaucoma. Eye (Lond). 2002;16:44–9. CrossRef
Globe DR, Schoua-Glusberg A, Paz S, et al. Using focus groups to develop a culturally sensitive methodology for epidemiological surveys in a Latino population: findings from the Los Angeles Latino Eye Study (LALES). Ethn Dis. 2002;12:259–66. PubMed
McKean-Cowdin R, Wang Y, Wu J, et al. Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology. 2008;115(941–948):e941. CrossRef
van Gestel A, Webers CA, Beckers HJ, et al. The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye (Lond). 2010;24:1759–69. CrossRef
Cheng HC, Guo CY, Chen MJ, et al. Patient-reported vision-related quality of life differences between superior and inferior hemifield visual field defects in primary open-angle glaucoma. JAMA Ophthalmol. 2015;133:269–75.
Wang SY, Singh K, Lin SC. Prevalence and predictors of depression among participants with glaucoma in a nationally representative population sample. Am J Ophthalmol. 2012;154(436–444):e432.
Thomas SA, Friedmann E, Kao CW, et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care. 2006;15:389–98. PubMed
Skalicky SE, Goldberg I, McCluskey P. Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol. 2012;153(1–9):e2. PubMed
Baudouin C, Renard JP, Nordmann JP, et al. Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension. Eur J Ophthalmol. 2013;23:47–54.
Burr J, Azuara-Blanco A, Avenell A, Tuulonen A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev. 2012;9:CD004399. PubMed
Friedman SM, Munoz B, Rubin GS, et al. Characteristics of discrepancies between self-reported visual function and measured reading speed. Salisbury Eye Evaluation Project Team. Invest Ophthalmol Vis Sci. 1999;40:858–64. PubMed
Gilhotra JS, Mitchell P, Ivers R, Cumming RG. Impaired vision and other factors associated with driving cessation in the elderly: the Blue Mountains Eye Study. Clin Exp Ophthalmol. 2001;29:104–7. CrossRef
Blane A. Through the looking glass: a review of the literature investigating the impact of glaucoma on crash risk, driving performance, and driver self-regulation in older drivers. J Glaucoma. 2014;25:113–21.
Lee PP. Outcomes and endpoints in glaucoma. J Glaucoma. 1996;5:295–7. PubMed
- Quality of Life in Glaucoma: A Review of the Literature
Anastasios G. P. Konstas
- Springer Healthcare
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II